Updated Mar 25, 2026
Shotsy GLP-1 Tracker
Individuals using GLP-1 receptor agonists (semaglutide, tirzepatide, etc.) for weight management or Type 2 Diabetes who value data-driven insights and privacy.
What Is Shotsy GLP-1 Tracker?
What users think
Key Features
Visualizes drug concentration over time using peer-reviewed clinical data.
Uses local device storage and private iCloud sync for medical data.
Supports simultaneous tracking of injections and oral pills with separate schedules.
Syncs weight, calories, and protein data automatically.
Recent User Sentiment
“Recent user voice shows a mixed sentiment. Users appreciate medication level visualization and ease of use, but report feature paywalling and high subscription cost.”
What Users Love
I love being able to track how much Tirzepatide is currently active especially since I inject split dosing.
Simple easy practical application for tracking injections, calories, locations, etc.
Pain Points
They decided to add what was already a free feature the estimated levels to a premium feature making you pay.
Problem is that feature alone isn’t worth $10/mo. Even at $40/yr it’s just too much.
High confidence · 49 reviews available
App Store Performance
| Chart | Rank | Change |
|---|---|---|
| Grossing | #71 | ▼4 |
Pros and Cons
Pros
- Unique clinical data-driven medication level visualization
- High-quality, intuitive UI/UX for complex medical logging
- Privacy-centric data architecture using iCloud
- Strong niche market fit within the GLP-1 boom
Cons
- Aggressive paywalling of previously free core features
- High subscription cost ($10/mo) leading to user churn
- Occasional data persistence and reliability bugs
- Lack of multi-platform support (iOS only)
Market Outlook
Growth Opportunities
- Expansion to Android to capture broader market share
- Partnerships with GLP-1 telehealth providers
- Introduction of a mid-tier pricing model or one-time purchase
- Developing community or educational content to increase LTV
Market Threats
- Competitors offering level-tracking features for free
- Official tracking apps from pharmaceutical companies (Novo Nordisk/Eli Lilly)
- Negative sentiment trend impacting App Store conversion
- Privacy concerns regarding new opt-out data collection policies
Key Takeaways
Shotsy GLP-1 Tracker is a divisive health & fitness app that is available. With a 4.8/5 rating from 20.1K reviews, it receives mixed feedback from users. Users particularly appreciate medication level visualization, though feature paywalling remains a common concern.
Best for: Individuals using GLP-1 receptor agonists (semaglutide, tirzepatide, etc.) for weight management or Type 2 Diabetes who value data-driven insights and privacy.
App Details & Pricing
Model: subscription
The app has recently moved core features (like level tracking) behind a paywall, transitioning from a growth-focused free model to a high-margin subscription model. This has caused significant user friction due to the high price point.
iOS Version
3.0.2
Release Date
May 29, 2024
iOS Price
Free